Proton-Pump Inhibitor Utilization Associated With the Change to Nonpreferred Formulary Status for Esomeprazole in the TRICARE Formulary

BACKGROUND: Inhibitor (PPI) esomeprazole in the third copayment tier on the TRICARE formulary on July 17, 2005. The change to nonpreferred formulary status for esomeprazole included a $13 copayment increase (from $9.00 to $22.00) for either a 30-day supply purchased from a community pharmacy or a 90...

Descripción completa

Detalles Bibliográficos
Autores principales: Linton, Andrea, Bacon, Thomas, Peterson, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2009
Materias:
Formulary Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437574/
https://www.ncbi.nlm.nih.gov/pubmed/19125549
http://dx.doi.org/10.18553/jmcp.2009.15.1.42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437574/
https://www.ncbi.nlm.nih.gov/pubmed/19125549
http://dx.doi.org/10.18553/jmcp.2009.15.1.42

Ejemplares similares